Transaction · 0001415889-25-001722

Person Julie

Person Julie, CAO, reported a transaction classified as grant at Third Harmonic Bio, Inc. involving 12500.000000 shares for an estimated $0.00. Reported holdings after the transaction were 12500.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACAO
THRDThird Harmonic Bio, Inc.
Filing timeJan 17
Trade dateJan 15, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
Pre-filing
Returns since

THRD price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
THRD since 2025-01-17Filed 594 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001415889-25-001722
Restricted Stock Unit
Transaction date
Jan 15, 2025
Filed Jan 17, 2025, 11:07 PM · 2d delay
Shares
12.5k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
12.5k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Derivative Transaction Direct Ownership Large Holdings Increase
-6score
Filing-only score

-6

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CHIEF ADMINISTRATIVE OFFICER

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The equity awards of the Reporting Person in this Form 4 were approved on December 17, 2024 by the board of directors as part of the annual refresh equity grant process of the registrant with an effec…

  2. F2

    The option vests over a four-year period: 2.0833% shall vest on February 15, 2025, after which 2.0833% of the total shares vest monthly, subject to contioued service through each vestiog date.

  3. F3

    Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

  4. F4

    The RSU vests over a four-year period: 1/4 on Febuary 15, 2026, after which 1/4 of the total shares vest annually, subject to contioued service through each vestiog date.

Original filing · 0001415889-25-001722
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

THRD